Coming In Hot: Fintech Is Growing, And So Is USAM Group!
Washingtoner/10136886

NEW YORK - Washingtoner -- NEW YORK - USAM Group, the distinctive provider of sales, marketing, and advisory services to growth-stage financial technology innovators, is proud to announce the expansion of our client portfolio and our staff, to the benefit of fintech buyers and sellers alike.

New Fintech Firms
We've added five exceptional products that help financial institutions make money, save time, avoid risk – and even go greener!  Our newest suppliers:

• Urvin.ai gets your AI out of the lab and into production – and makes sure you're not exposed to cybersecurity risks as a result.
• TransFICC is a powerful, reliable choice for firms that want seamless venue connectivity as an alternative to vendor-based fixed-income trading platforms.
• MAP Digital has spent 20 years perfecting the event management platform, processes, and people that work together to deliver flawless experiences for hosts and their in-person and online participants alike – before, during, and after the big day.
• eLoomina uses behavioral science and AI to raise red flags when employee behavior threatens misconduct – letting firms spot potential fraud and other problems before they cause actual damages.
• Bodo.ai lets data scientists automatically scale high-level code to efficient multi-core processing, significantly improving time-to-market for new analytics and generating big reductions in compute time - saving money and reducing carbon footprints.

Newly Hired Team Members
Our newest team members are hard at work helping customers find the best solutions, improving insight for our vendors, and perfecting our unique, data-driven sales benchmarks:

• Jean Ratanaphaitun – dedicated and highly organized IT Analyst and Sales Ops Manager
• Matt Meinel – inventive and tech-savvy Enterprise Sales Executive
• Mary Marland – focused and connected Strategic Advisor and Sales Executive
• Kayla Macleod – creative and energetic Digital Marketing Manager
• Jiahui Lu – clever and curious Data Scientist and Programmer

Visit our brand-new website for full details of all our best-in-class fintech suppliers and team members

More on Washingtoner

• Tacoma: Nominations Open Now Through March 17 for 2026 Historic Preservation Awards
• Sleep Basil Unveils Revamped Natural Latex Mattress Collection Page for Cooler, Cleaner, Better-Aligned Sleep
• Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
• New Ordinance Would Prohibit Use of Private Property for Detention Facilities in Spokane
• Announcing the Winners of the 2026 Best of Northwest Travel

About USAM Group
USAM's sales and marketing system serves growth-stage fintech trailblazers.  We close deals for our supplier clients by following our proven process: we articulate the essential value of each product, design and execute a strategic plan to create awareness, and build the sales pipeline to generate revenue.

Our unique shared-service approach gives our supplier clients a global, cross-functional team of experienced business development professionals – at far lower cost and faster ROI than hiring a comparable staff.  Fintech consumers benefit because we help them save time and avoid risk by bringing a portfolio of new solutions that we've pre-screened for quality and value.

With headquarters in New York City, USAM has feet on the ground in major financial centers including London, Toronto, Chicago, and Singapore.

Visit us at http://www.usamgroup.com



More on Washingtoner

• Tacoma: Street Closures Projected to Start the Week of February 23 for Residential Street Restoration Program Maintenance Work
• City of Tacoma Expands Garbage Can Program in Response to Community Feedback
• FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
• $2.7 Million 2025 Revenue; All Time Record Sales Growth; 6 Profitable Quarters for Homebuilding Industry: Innovative Designs (Stock Symbol: IVDN)
• CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety